The rise of Sildenafil initially sparked a period of growth for major pharmaceutical companies, but recent changes present a uncertain picture for those considering a stake. Off-patent competitors are reducing https://graysonkigq835721.activoblog.com/52290485/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-investment